Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Whitlock

Showing results (231-240 of 272) with videos related to

Pageof 28
Sort By:
Paediatrics & Child Health|October 27, 2023
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experienceGabriel Revon-Riviere, Leah C Young, Elizabeth A Stephenson, et al.
BMC Oral Health|November 3, 2022
A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitisBianca A Newman, Claire N Rosebrough, Ryan A Tamashiro, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Cancer|April 29, 2014
AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemiaTodd M Cooper, Todd A Alonzo, Robert B Gerbing, et al.
Genome Announcements|January 14, 2017
Genome Sequence of Porphyromonas gingivalis Strain 381Ryan P Chastain-Gross, Gary Xie, Myriam Bélanger, et al.
Genome Announcements|March 11, 2017
Genome Sequence of <i>Porphyromonas gingivalis</i> Strain A7A1-28Gary Xie, Ryan P Chastain-Gross, Myriam Bélanger, et al.
Blood|May 6, 2010
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology GroupKelly W Maloney, William L Carroll, Andrew J Carroll, et al.
Haematologica|February 1, 2020
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433Glen Lew, Yichen Chen, Xiaomin Lu, et al.
Leukemia & Lymphoma|April 25, 2026
Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemiaMarie-Claude Pelland-Marcotte, Chantal Éthier, Alexis Manirakiza, et al.
Cancers|June 24, 2022
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical TrialArif Manji, Yvan Samson, Rebecca J Deyell, et al.
Pageof 28

Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
Paediatrics & Child Health|October 27, 2023
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experienceGabriel Revon-Riviere, Leah C Young, Elizabeth A Stephenson, et al.
BMC Oral Health|November 3, 2022
A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitisBianca A Newman, Claire N Rosebrough, Ryan A Tamashiro, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Cancer|April 29, 2014
AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemiaTodd M Cooper, Todd A Alonzo, Robert B Gerbing, et al.
Genome Announcements|January 14, 2017
Genome Sequence of Porphyromonas gingivalis Strain 381Ryan P Chastain-Gross, Gary Xie, Myriam Bélanger, et al.
Genome Announcements|March 11, 2017
Genome Sequence of <i>Porphyromonas gingivalis</i> Strain A7A1-28Gary Xie, Ryan P Chastain-Gross, Myriam Bélanger, et al.
Blood|May 6, 2010
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology GroupKelly W Maloney, William L Carroll, Andrew J Carroll, et al.
Haematologica|February 1, 2020
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433Glen Lew, Yichen Chen, Xiaomin Lu, et al.
Leukemia & Lymphoma|April 25, 2026
Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemiaMarie-Claude Pelland-Marcotte, Chantal Éthier, Alexis Manirakiza, et al.
Cancers|June 24, 2022
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical TrialArif Manji, Yvan Samson, Rebecca J Deyell, et al.
Pageof 28